Mak Michael Y K

Felfeli Tina, Juncal Verena R, Hillier Roxane J, Mak Michael Y K, Wong David T, Berger Alan R et al.

This study found early aqueous humor cytokine levels, particularly VEGF at 2 months, predict long-term anti-VEGF response in diabetic macular edema, potentially guiding personalized treatment for better outcomes.

Hillier Roxane J, Ojaimi Elvis, Wong David T, Mak Michael Y K, Berger Alan R, Kohly Radha P et al.

This study found that baseline aqueous ICAM-1 and VEGF levels predict anatomic response to ranibizumab in DME. Higher ICAM-1 and lower VEGF indicate better outcomes, potentially guiding personalized treatment.

Hillier Roxane J, Ojaimi Elvis, Wong David T, Mak Michael Y K, Berger Alan R, Kohly Radha P et al.

This study found aqueous ICAM-1 levels correlate with diabetic macular edema severity (macular volume), suggesting it could be a useful biomarker for disease management.